Last reviewed · How we verify

NCT03850106

Effects of INDUS810 on Body Composition, Muscular Performance, and Training Adaptations

Completed NA Last updated 18 February 2020
What this trial tests

NA trial testing Placebo in Weakness, Muscle in 67 participants. Completed in 30 April 2019.

Timeline
11 July 2018
Primary endpoint
15 March 2019
30 April 2019

Quick facts

Lead sponsorThe Center for Applied Health Sciences, LLC
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment67
Start date11 July 2018
Primary completion15 March 2019
Estimated completion30 April 2019
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

The Center for Applied Health Sciences, LLC

Who can join

Adults 18 to 45, male only, with Weakness, Muscle. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this 12-week, interventional study is to determine the effects of oral supplementation with Indus810 (dietary supplement with active ingredient Fenugreek) on body composition, muscular performance, and training adaptations

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Weakness, Muscle

Currently open trials in the same condition.

Other The Center for Applied Health Sciences, LLC trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03850106.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing